141 related articles for article (PubMed ID: 36841468)
1. Anaerobic energy metabolism in human microaerophile parasites.
Carvalho-de-Araújo AD; Carvalho-Kelly LF; Meyer-Fernandes JR
Exp Parasitol; 2023 Apr; 247():108492. PubMed ID: 36841468
[TBL] [Abstract][Full Text] [Related]
2. Drug targets and mechanisms of resistance in the anaerobic protozoa.
Upcroft P; Upcroft JA
Clin Microbiol Rev; 2001 Jan; 14(1):150-64. PubMed ID: 11148007
[TBL] [Abstract][Full Text] [Related]
3. In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites.
Cedillo-Rivera R; Chávez B; González-Robles A; Tapia A; Yépez-Mulia L
J Eukaryot Microbiol; 2002; 49(3):201-8. PubMed ID: 12120985
[TBL] [Abstract][Full Text] [Related]
4. Highly Potent 1
Kumar S; Bains T; Won Kim AS; Tam C; Kim J; Cheng LW; Land KM; Debnath A; Kumar V
Front Cell Infect Microbiol; 2018; 8():380. PubMed ID: 30425970
[TBL] [Abstract][Full Text] [Related]
5. Current and future perspectives on the chemotherapy of the parasitic protozoa Trichomonas vaginalis and Entamoeba histolytica.
Moya IA; Su Z; Honek JF
Future Med Chem; 2009 Jul; 1(4):619-43. PubMed ID: 21426030
[TBL] [Abstract][Full Text] [Related]
6. Drug susceptibility testing in microaerophilic parasites: Cysteine strongly affects the effectivities of metronidazole and auranofin, a novel and promising antimicrobial.
Leitsch D
Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):321-327. PubMed ID: 28910741
[TBL] [Abstract][Full Text] [Related]
7. Pyridyl Methylsulfinyl Benzimidazole Derivatives as Promising Agents against
Hernández-Ochoa B; Martínez-Rosas V; Morales-Luna L; Calderón-Jaimes E; Rocha-Ramírez LM; Ortega-Cuellar D; Rufino-González Y; González-Valdez A; Arreguin-Espinosa R; Enríquez-Flores S; Castillo-Rodríguez RA; Cárdenas-Rodríguez N; Wong-Baeza C; Baeza-Ramírez I; Gómez-Manzo S
Molecules; 2022 Dec; 27(24):. PubMed ID: 36558035
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles released by anaerobic protozoan parasites: Current situation.
Nievas YR; Lizarraga A; Salas N; Cóceres VM; de Miguel N
Cell Microbiol; 2020 Nov; 22(11):e13257. PubMed ID: 32858768
[TBL] [Abstract][Full Text] [Related]
9. Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis.
Jarrad AM; Debnath A; Miyamoto Y; Hansford KA; Pelingon R; Butler MS; Bains T; Karoli T; Blaskovich MA; Eckmann L; Cooper MA
Eur J Med Chem; 2016 Sep; 120():353-62. PubMed ID: 27236016
[TBL] [Abstract][Full Text] [Related]
10. Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.
Ali V; Nozaki T
Clin Microbiol Rev; 2007 Jan; 20(1):164-87. PubMed ID: 17223627
[TBL] [Abstract][Full Text] [Related]
11. Keto-acid oxidoreductases in the anaerobic protozoa.
Upcroft JA; Upcroft P
J Eukaryot Microbiol; 1999; 46(4):447-9. PubMed ID: 10461388
[TBL] [Abstract][Full Text] [Related]
12. Unveiling the role of EVs in anaerobic parasitic protozoa.
Sabatke B; Gavinho B; Coceres V; de Miguel N; Ramirez MI
Mol Immunol; 2021 May; 133():34-43. PubMed ID: 33621941
[TBL] [Abstract][Full Text] [Related]
13. Activity of methylgerambullin from Glycosmis species (Rutaceae) against Entamoeba histolytica and Giardia duodenalis in vitro.
Drinić M; Raninger A; Zraunig A; Astelbauer F; Leitsch D; Obwaller A; Walochnik J; Greger H; Duchene M
Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():109-117. PubMed ID: 31472356
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiprotozoal activity of novel 2-{[2-(1H-imidazol-1-yl)ethyl]sulfanyl}-1H-benzimidazole derivatives.
Pérez-Villanueva J; Hernández-Campos A; Yépez-Mulia L; Méndez-Cuesta C; Méndez-Lucio O; Hernández-Luis F; Castillo R
Bioorg Med Chem Lett; 2013 Jul; 23(14):4221-4. PubMed ID: 23731944
[TBL] [Abstract][Full Text] [Related]
15. Energy production in Entamoeba histolytica: new perspectives in rational drug design.
Saavedra-Lira E; Pérez-Montfort R
Arch Med Res; 1996; 27(3):257-64. PubMed ID: 8854380
[TBL] [Abstract][Full Text] [Related]
16. Novel therapeutic opportunities for
Arrighi F; Granese A; Chimenti P; Guglielmi P
Expert Opin Ther Pat; 2023 Mar; 33(3):211-245. PubMed ID: 37099697
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in
Graves KJ; Novak J; Secor WE; Kissinger PJ; Schwebke JR; Muzny CA
Parasitology; 2020 Nov; 147(13):1383-1391. PubMed ID: 32729451
[TBL] [Abstract][Full Text] [Related]
18. The antimicrobial peptides LL-37, KR-20, FK-13 and KR-12 inhibit the growth of a sensitive and a metronidazole-resistant strain of Trichomonas vaginalis.
Ramírez-Ledesma MG; Rodríguez MC; Alva-Murillo N; Avila EE
Parasitol Res; 2022 Dec; 121(12):3503-3512. PubMed ID: 36171407
[TBL] [Abstract][Full Text] [Related]
19. Molecular biology of the amitochondriate parasites, Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis.
Vanacova S; Liston DR; Tachezy J; Johnson PJ
Int J Parasitol; 2003 Mar; 33(3):235-55. PubMed ID: 12670510
[TBL] [Abstract][Full Text] [Related]
20. Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence.
Katiyar SK; Gordon VR; McLaughlin GL; Edlind TD
Antimicrob Agents Chemother; 1994 Sep; 38(9):2086-90. PubMed ID: 7811023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
